Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates
Portfolio Pulse from
Zymeworks Inc. (ZYME) reported a Q4 loss of $0.31 per share, slightly better than the Zacks Consensus Estimate of a $0.32 loss. However, this is a larger loss compared to the $0.20 per share loss from the previous year.
March 05, 2025 | 11:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Zymeworks Inc. reported a Q4 loss of $0.31 per share, which was slightly better than expected but worse than the previous year's loss. This could lead to short-term volatility in the stock price.
The reported loss was slightly better than the consensus estimate, which might have a minor positive impact. However, the larger loss compared to the previous year could lead to negative sentiment, likely causing short-term downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100